These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28199203)

  • 81. The D2 receptor is critical in mediating opiate motivation only in opiate-dependent and withdrawn mice.
    Dockstader CL; Rubinstein M; Grandy DK; Low MJ; van der Kooy D
    Eur J Neurosci; 2001 Mar; 13(5):995-1001. PubMed ID: 11264672
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.
    Soyka M; Kranzler HR; van den Brink W; Krystal J; Möller HJ; Kasper S;
    World J Biol Psychiatry; 2011 Apr; 12(3):160-87. PubMed ID: 21486104
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats.
    Vargas-Perez H; Ting-A Kee R; Walton CH; Hansen DM; Razavi R; Clarke L; Bufalino MR; Allison DW; Steffensen SC; van der Kooy D
    Science; 2009 Jun; 324(5935):1732-4. PubMed ID: 19478142
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Opiate receptors and endogenous opiates: panorama of opiate research.
    Szara S
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(1):3-15. PubMed ID: 6125996
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction.
    Guo Y; Wang HL; Xiang XH; Zhao Y
    Neurosci Biobehav Rev; 2009 Jun; 33(6):864-73. PubMed ID: 19428497
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Acupuncture-related techniques for the treatment of opiate addiction: a case of translational medicine.
    Han J; Cui C; Wu L
    Front Med; 2011 Jun; 5(2):141-50. PubMed ID: 21695618
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Substance use disorder a bio-directional subset of reward deficiency syndrome.
    Blum K; Gold M; Demetrovics Z; Archer T; Thanos PK; Baron D; Badgaiyan RD
    Front Biosci (Landmark Ed); 2017 Jun; 22(9):1534-1548. PubMed ID: 28410131
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
    Blum K; Dennen CA; Elman I; Bowirrat A; Thanos PK; Badgaiyan RD; Downs BW; Bagchi D; Baron D; Braverman ER; Gupta A; Green R; McLaughlin T; Barh D; Gold MS
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294858
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dopamine Genetics and Function in Food and Substance Abuse.
    Blum K; Oscar-Berman M; Barh D; Giordano J; Gold M
    J Genet Syndr Gene Ther; 2013 Feb; 4(121):. PubMed ID: 23543775
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Overcoming reward deficiency syndrome by the induction of "dopamine homeostasis" instead of opioids for addiction: illusion or reality?
    Blum K; Soni D; Badgaiyan RD; Baron D
    J Osteopath Med; 2022 Apr; 122(7):333-337. PubMed ID: 35411759
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).
    Kenneth B; Edward MJ; Marjorie GLC; David B; Bruce S; Panayotis TK; William DB; Davis S; Lisa L; Eric BR; Mark M; David M; Lyle F; Rajendra BD
    CPQ Neurol Psychol; 2018; 1(2):. PubMed ID: 30957097
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-Induced Hyperalgesia.
    Brewer R; Blum K; Bowirrat A; Modestino EJ; Baron D; Badgaiyan RD; Moran M; Boyett B; Gold MS
    Curr Psychopharmacol; 2020; 9(3):164-184. PubMed ID: 37361136
    [TBL] [Abstract][Full Text] [Related]  

  • 93. DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave
    Bajaj A; Blum K; Bowirrat A; Gupta A; Baron D; Fugel D; Nicholson A; Fitch T; Downs BW; Bagchi D; Dennen CA; Badgaiyan RD
    J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143203
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
    Blum K; Raza A; Schultz T; Jalali R; Green R; Brewer R; Thanos PK; McLaughlin T; Baron D; Bowirrat A; Elman I; Downs BW; Bagchi D; Badgaiyan RD
    Acta Sci Neurol; 2021 Feb; 4(2):17-24. PubMed ID: 33681869
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Beyond Mor: Can Induction of Dopamine Homeostasis Along with Electrotherapy Attenuate the Opioid Crisis?
    Blum K; Bowirrat A; Braverman ER; Dennen C; Zeine F; Jafari N; Sunder K; Thanos PK; Baron D; Barh D; Gupta A; Bagchi D; Gold MS; Badgaiyan RD
    Clin Exp Psychol; 2023 Mar; 9(2):1-3. PubMed ID: 37363693
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Are We Getting High Cause the Thrill is Gone?
    Blum K; Mclaughlin T; Gold MS; Gondre-Lewis MC; Thanos PK; Elman I; Baron D; Bowirrat A; Barh D; Khalsa J; Hanna C; Jafari N; Zeine F; Braverman ER; Dennen C; Makale MT; Makale M; Sunder K; Murphy KT; Badgaiyan RD
    J Addict Psychiatry; 2023; 7(1):5-516. PubMed ID: 38164471
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Endogenous opiates: 1993.
    Olson GA; Olson RD; Kastin AJ
    Peptides; 1994; 15(8):1513-56. PubMed ID: 7700854
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?
    Blum K; McLaughlin T; Bowirrat A; Modestino EJ; Baron D; Gomez LL; Ceccanti M; Braverman ER; Thanos PK; Cadet JL; Elman I; Badgaiyan RD; Jalali R; Green R; Simpatico TA; Gupta A; Gold MS
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207809
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Dopaminergic Neurogenetics of Sleep Disorders in Reward Deficiency Syndrome (RDS).
    Blum K; Oscar-Berman M; Badgaiyan RD; Khurshid KA; Gold MS
    J Sleep Disord Ther; 2014 Feb; 3(2):126. PubMed ID: 25657892
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Biomarkers to predict staging and treatment response in opioid dependence: A narrative review.
    Vorspan F; Marie-Claire C; Bellivier F; Bloch V
    Drug Dev Res; 2021 Aug; 82(5):668-677. PubMed ID: 33416203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.